Massive Bio Email Format
Hospitals and Health CareIstanbul, Turkey51-200 Employees
Massive Bio is a health-tech company focused on expanding access to cancer clinical trials. Its platform uses AI to match patients with suitable trials across 17 countries in North America, Europe, and LATAM, aiming to overcome barriers related to location, income, and cancer type. The company partners with pharmaceutical firms, contract research organizations, and healthcare institutions to speed trial enrollment, reduce dropout, and generate real-world evidence. Based in Istanbul, Turkey, Massive Bio operates as a mid-sized organization with a global reach. It has onboarded over 200,000 patients and maintains a network of more than 60 pharma and CRO customers and over 130 strategic partners. In June 2026, Massive Bio announced an integration with Optellum, combining Optellum's AI-based lung cancer risk assessment with Massive Bio's AI-driven trial-matching platform.